Hunan Hansen Pharmaceutical Co Ltd (002412) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hunan Hansen Pharmaceutical Co Ltd (002412) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.51 Million ≈ $7.68 Million USD) by net assets (CN¥2.26 Billion ≈ $330.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002412 net asset quality score to measure how much of total assets are equity-financed.
Hunan Hansen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Hunan Hansen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Hunan Hansen Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Hunan Hansen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Hansen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Roma Green Finance Limited Ordinary Shares
NASDAQ:ROMA
|
-0.157x |
|
Zhejiang Zoenn Design Co Ltd
SHE:300901
|
0.050x |
|
El Pollo Loco Holdings Inc
NASDAQ:LOCO
|
0.043x |
|
Fujian Green Pine Co Ltd
SHE:300132
|
-0.038x |
|
SunOpta Inc.
NASDAQ:STKL
|
0.092x |
|
Ichitan Group Public Company Limited
BK:ICHI-R
|
-0.023x |
|
Korea District Heating Corp
KO:071320
|
0.039x |
|
Alpha Hpa Ltd
AU:A4N
|
-0.107x |
Annual Cash Flow Conversion Efficiency for Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 002412 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.38 Billion ≈ $348.40 Million |
CN¥245.38 Million ≈ $35.91 Million |
0.103x | +73.63% |
| 2024-12-31 | CN¥2.20 Billion ≈ $322.42 Million |
CN¥130.78 Million ≈ $19.14 Million |
0.059x | -27.60% |
| 2023-12-31 | CN¥1.96 Billion ≈ $287.25 Million |
CN¥160.95 Million ≈ $23.55 Million |
0.082x | +7.99% |
| 2022-12-31 | CN¥1.89 Billion ≈ $277.17 Million |
CN¥143.81 Million ≈ $21.04 Million |
0.076x | -37.76% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.95 Million |
CN¥212.54 Million ≈ $31.10 Million |
0.122x | +19.95% |
| 2020-12-31 | CN¥1.59 Billion ≈ $233.36 Million |
CN¥162.19 Million ≈ $23.73 Million |
0.102x | -5.76% |
| 2019-12-31 | CN¥1.53 Billion ≈ $223.88 Million |
CN¥165.11 Million ≈ $24.16 Million |
0.108x | -32.36% |
| 2018-12-31 | CN¥1.36 Billion ≈ $199.50 Million |
CN¥217.52 Million ≈ $31.83 Million |
0.160x | +81.50% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.41 Million |
CN¥107.18 Million ≈ $15.68 Million |
0.088x | -31.35% |
| 2016-12-31 | CN¥1.26 Billion ≈ $184.16 Million |
CN¥161.16 Million ≈ $23.58 Million |
0.128x | +152.48% |
| 2015-12-31 | CN¥1.25 Billion ≈ $183.42 Million |
CN¥63.57 Million ≈ $9.30 Million |
0.051x | -31.23% |
| 2014-12-31 | CN¥1.15 Billion ≈ $168.75 Million |
CN¥85.05 Million ≈ $12.44 Million |
0.074x | +7.35% |
| 2013-12-31 | CN¥1.11 Billion ≈ $162.08 Million |
CN¥76.09 Million ≈ $11.13 Million |
0.069x | -33.85% |
| 2012-12-31 | CN¥965.11 Million ≈ $141.23 Million |
CN¥100.23 Million ≈ $14.67 Million |
0.104x | +70.44% |
| 2011-12-31 | CN¥883.65 Million ≈ $129.31 Million |
CN¥53.84 Million ≈ $7.88 Million |
0.061x | +157.83% |
| 2010-12-31 | CN¥898.82 Million ≈ $131.53 Million |
CN¥21.24 Million ≈ $3.11 Million |
0.024x | -89.66% |
| 2009-12-31 | CN¥179.51 Million ≈ $26.27 Million |
CN¥41.02 Million ≈ $6.00 Million |
0.228x | -12.30% |
| 2008-12-31 | CN¥130.26 Million ≈ $19.06 Million |
CN¥33.94 Million ≈ $4.97 Million |
0.261x | -39.43% |
| 2007-12-31 | CN¥87.77 Million ≈ $12.84 Million |
CN¥37.75 Million ≈ $5.52 Million |
0.430x | -- |
About Hunan Hansen Pharmaceutical Co Ltd
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syru… Read more